Navigation Links
Xenon Named Life Sciences Company of the Year by LifeSciences British Columbia
Date:4/8/2013

VANCOUVER, Canada, April 8, 2013 /PRNewswire/ -- Xenon Pharmaceuticals Inc. is pleased to announce that it has been awarded the LifeSciences British Columbia Life Sciences Company of the Year Award for 2013. 

(Photo:  http://photos.prnewswire.com/prnh/20130408/SF89970)

The LifeSciences British Columbia Awards took take place on Thursday, April 4 at the Vancouver Convention Centre with several hundred guests representing the British Columbia life sciences community. 

"We are honored to be recognized by our industry peers in this way," commented Simon Pimstone , Xenon's President and CEO.  "This is the beginning of a very exciting year for Xenon.  We've worked diligently and deliberately to create strong partnerships with top tier pharmaceutical companies and to develop a deep and diverse pipeline of products.  One of Xenon's early technologies is now in an approved product to treat lipoprotein lipase deficiency, we have a late stage clinical program initiating for our novel pain medicine and an early development stage product for the treatment of anemia.  We look forward to an exciting year at Xenon as our products advance on the market and in the clinic." 

About Xenon Pharmaceuticals Inc. Xenon is a privately owned, clinical genetics-based drug discovery and development company engaged in developing novel therapies for rare diseases. For more information, visit the Company's website at http://www.xenon-pharma.com.

For more information regarding this press release, contact: Dr. Robin Sherrington , SVP Business & Corporate Development  (604) 484-3300, ddunn@xenon-pharma.com

This release contains forward-looking statements that are not based on historical fact. These forward-looking statements involve risks, uncertainties and other factors that may cause the actual results, events or developments to be materially different from those expressed or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on such forward-looking statements.


'/>"/>
SOURCE Xenon Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Xenon Announces Appointment of EVP, Research & Development
2. Covis Pharmaceuticals, Inc Named US Distributor For Five Additional Products
3. SynCardias Companion 2 Driver Named a Finalist in the Medical Design Excellence Awards
4. Ultroz Elite Wearable Ultrasonic Therapy System was Named as Finalist in the 2013 Medical Design Excellence Awards
5. Nick Pace Named EVP -- Operations, Compliance, and Regulatory
6. Best Healthcare Websites of 2013 to be Named by Web Marketing Association in 17th Annual WebAward Competition
7. Deacom Named a Finalist for 2013 SmartCEO Voltage Awards
8. DelMar Pharma Named to Rocket Builders 2013"Ready to Rocket" List
9. Steven Ek Named President and CEO of Arthrosurface
10. Henry Schein Named to FORTUNEs List of Most Admired Companies for 12th Consecutive Year
11. Joachim Schorr, PhD, Named Chief Scientific Officer at Caris Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... 19, 2017  SARES•REGIS Group leased the first ... at Conejo Spectrum Business Park in ... Biotherapeutics, Inc. , a biopharmaceutical company developing meaningful ... that have been underserved by scientific innovation, with ... cancer, autoimmune and infectious disease. Before ...
(Date:4/18/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 6.35% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College is introducing enhancements ... their careers. Beginning in the fall of 2017, Emmanuel’s program will allow registered nurses ... as 16 months and for as little as $14,528. These changes will enable nurses ...
(Date:4/24/2017)... , ... April 24, 2017 , ... Michael Vick announced ... transforming the quarterback position. The former overall number one pick in the 2001 NFL ... career. He holds the record for the most career rushing yards by a quarterback ...
(Date:4/24/2017)... ... April 24, 2017 , ... Ridgecrest Herbals makes it a ... new strategies to reduce waste, and support renewable energy. They believe this is a ... nature to find solutions for health issues, and maintain that destroying the environment in ...
(Date:4/24/2017)... Boulder, CO (PRWEB) , ... April 24, 2017 ... ... 2017 American Educational Research Association’s Outstanding Public Communication of Education Research Award. The ... the public, including education communities. It recognizes a scholar who has demonstrated the ...
(Date:4/24/2017)... ... ... Bright Pink , a national non-profit organization focusing on the prevention and early detection of ... is proud to announce Katie Thiede as their new Chief Executive Officer. In January, founder ... of the Board and launched a national search to find a visionary new leader to ...
Breaking Medicine News(10 mins):